Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Traveller’s Diarrhoea Treatment Market: By Drug Type: Oral Rehydration Therapy (ORS), Antidiarrhoeal Agents, Vaccines/Prophylactics; By Pathogen; By Age; By Distribution Channel; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments
Global Traveller’s Diarrhoea Treatment Market Outlook
The global traveller’s diarrhoea treatment market is expected to grow at a CAGR of 6% in the forecast period of 2022-2027.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Huge Number of Market Players to Aid the Market Growth of Traveller’s Diarrhoea Treatment
The market growth of traveller’s diarrhoea treatment is being driven by the huge number of market players that offer significant competition. The market is stimulated by the growing emphasis on the adoption of the latest technological advancement by manufacturers of drugs, along with offering specialized distribution channels for drugs for the treatment of traveller’s diarrhoea. Moreover, the latest product development to formulate specialized drugs and vaccines for the treatment of traveller’s diarrhoea with preventive effect, is shifting the market scenario for the treatment of traveller’s diarrhoea. In addition, the launch of new vaccine produced by the manufacturer is predicted to boost competition among the manufacturers of traveller’s diarrhoea treatment industry, further encouraging market growth.
Traveller’s Diarrhoea Treatment: Industry Definition and Segmentation
Traveller’s diarrhoea treatment is referred to a treatment for a condition in which intestine and stomach are infected, majorly caused by the unsanitary conditions while handling edibles. Traveller’s diarrhoea is characterised by frequent lose stools and abdominal cramps triggered by the consumption of contaminated food and unfiltered water.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
On the basis of drug type, the market is divided into:
- Oral Rehydration Therapy (ORS)
- Antidiarrhoeal Agents
- Vaccines/Prophylactics
- Others
Antidiarrhoeal agents are further divided into antibiotics, azithromycin, ciprofloxacin, quinolones, rifaximin, among others.
By pathogen, the industry is segmented into:
- Bacteria
- Viruses
- Protozoa
- Others
Based on age, the industry is categorized into:
- Adult
- Children
On the basis of distribution channel, the industry is segregated into:
- Hospital Pharmacies
- Drug Store
- Online
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Booming Tourism Business in the Developing Countries to Aid the Market Growth of Traveller’s Diarrhoea Treatment
The market growth of traveller’s diarrhoea treatment is being driven by the rising number of regular flyers and booming tourism business in developing countries. Further, the traveller’s diarrhoea treatment is crucial to the traveller’s itinerary and contributes significantly to the patient’s wellbeing while travelling abroad. In addition, the growing awareness among the masses about the traveller’s diarrhoea treatment is expected to provide impetus to the market growth of traveller’s diarrhoea treatment. Moreover, the ease and convenience in acquiring the treatment drugs for traveller’s diarrhoea, along with the availability of over the counter medications is expected to provide lucrative opportunities for the growth of traveller’s diarrhoea treatment industry.
Key Industry Players in the Global Traveller’s Diarrhoea Treatment Market
The report gives a detailed analysis of the following key players in the global traveller’s diarrhoea treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Bausch Health Companies Inc.
- COSMO Pharmaceuticals
- Immuron Ltd.
- Sanofi SA
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Drug Type, Pathogen, Age, Distribution Channel, Region |
| Breakup by Drug Type | Oral Rehydration Therapy (ORS), Antidiarrhoeal Agents, Vaccines/Prophylactics, Others |
| Breakup by Pathogen | Bacteria, Viruses, Protozoa, Others |
| Breakup by Age | Adult, Children |
| Breakup by Distribution Channel | Hospital Pharmacies, Drug Store, Online |
| Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., Sanofi SA, Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Traveller’s Diarrhoea Treatment Market Analysis
8.1 Key Industry Highlights
8.2 Global Traveller’s Diarrhoea Treatment Historical Market (2017-2021)
8.3 Global Traveller’s Diarrhoea Treatment Market Forecast (2022-2027)
8.4 Global Traveller’s Diarrhoea Treatment Market by Drug Type
8.4.1 Oral Rehydration Therapy (ORS)
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Antidiarrhoeal Agents
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.2.4 Breakup by Type
8.4.2.4.1 Antibiotics
8.4.2.4.1.1 Market Share
8.4.2.4.1.2 Historical Trend (2017-2021)
8.4.2.4.1.3 Forecast Trend (2022-2027)
8.4.2.4.2 Azithromycin
8.4.2.4.2.1 Market Share
8.4.2.4.2.2 Historical Trend (2017-2021)
8.4.2.4.2.3 Forecast Trend (2022-2027)
8.4.2.4.3 Ciprofloxacin
8.4.2.4.3.1 Market Share
8.4.2.4.3.2 Historical Trend (2017-2021)
8.4.2.4.3.3 Forecast Trend (2022-2027)
8.4.2.4.4 Quinolones
8.4.2.4.4.1 Market Share
8.4.2.4.4.2 Historical Trend (2017-2021)
8.4.2.4.4.3 Forecast Trend (2022-2027)
8.4.2.4.5 Rifaximin
8.4.2.4.5.1 Market Share
8.4.2.4.5.2 Historical Trend (2017-2021)
8.4.2.4.5.3 Forecast Trend (2022-2027)
8.4.2.4.6 Others
8.4.3 Vaccines/Prophylactics
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Others
8.5 Global Traveller’s Diarrhoea Treatment Market by Pathogen
8.5.1 Bacteria
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2017-2021)
8.5.1.3 Forecast Trend (2022-2027)
8.5.2 Viruses
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2017-2021)
8.5.2.3 Forecast Trend (2022-2027)
8.5.3 Protozoa
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2017-2021)
8.5.3.3 Forecast Trend (2022-2027)
8.5.4 Others
8.6 Global Traveller’s Diarrhoea Treatment Market by Age
8.6.1 Adult
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2017-2021)
8.6.1.3 Forecast Trend (2022-2027)
8.6.2 Children
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2017-2021)
8.6.2.3 Forecast Trend (2022-2027)
8.7 Global Traveller’s Diarrhoea Treatment Market by Distribution Channel
8.7.1 Hospital Pharmacies
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2017-2021)
8.7.1.3 Forecast Trend (2022-2027)
8.7.2 Drug Store
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2017-2021)
8.7.2.3 Forecast Trend (2022-2027)
8.7.3 Online
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2017-2021)
8.7.3.3 Forecast Trend (2022-2027)
8.8 Global Traveller’s Diarrhoea Treatment Market by Region
8.8.1 Market Share
8.8.1.1 North America
8.8.1.2 Europe
8.8.1.3 Asia Pacific
8.8.1.4 Latin America
8.8.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Bausch Health Companies Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 COSMO Pharmaceuticals
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Immuron Ltd.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Sanofi SA
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Traveller’s Diarrhoea Treatment Market: Key Industry Highlights, 2016 and 2026
2. Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Drug Type (USD Billion), 2017-2021
3. Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Drug Type (USD Billion), 2022-2027
4. Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Pathogen (USD Billion), 2017-2021
5. Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Pathogen (USD Billion), 2022-2027
6. Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Age (USD Billion), 2017-2021
7. Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Age (USD Billion), 2022-2027
8. Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
9. Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
10. Global Traveller’s Diarrhoea Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
11. Global Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
12. North America Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13. North America Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Europe Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Europe Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Asia Pacific Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17. Asia Pacific Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18. Latin America Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
19. Latin America Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
20. Middle East and Africa Traveller’s Diarrhoea Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
21. Middle East and Africa Traveller’s Diarrhoea Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
22. Global Traveller’s Diarrhoea Treatment Market Structure
Key Questions Answered in the Report
The global traveller’s diarrhoea treatment market is projected to grow at a CAGR of 6% between 2021 and 2026.
The major drivers of the industry such as booming tourism business, rising awareness about the disease, rising demand from the developing regions, and huge number of market players are expected to aid the market growth.
The key market trend guiding the growth of the industry includes the availability of over the counter medications, consequently offering lucrative opportunities for the market growth.
What are the major regional markets of traveller’s diarrhoea treatment, according to the EMR report?
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading drug types in the market are oral rehydration therapy (ORS), antidiarrhoeal agents, and vaccines/prophylactics, among others.
The major pathogen segments in the industry are bacteria, viruses, and protozoa, among others.
The significant age segments in the market are adult and children.
The leading distribution channels in the industry are hospital pharmacies, drug store, and online.
The major players in the industry are Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., and Sanofi SA, among others.
Analyst Review
The global traveller’s diarrhoea treatment market is being driven by the rising tourism sector. Aided by the growing awareness about the disease, the market is expected to witness a healthy growth in the forecast period of 2022-2027, growing at a CAGR of 6%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on drug type, the market is segmented into oral rehydration therapy (ORS), antidiarrhoeal agents, and vaccines/prophylactics, among others. On the basis of pathogen, the industry is divided into bacteria, viruses, and protozoa, among others. By age, the market is categorised into adult and children. Based on distribution channel, the industry is segmented into hospital pharmacies, drug store, and online. The major regional markets for traveller’s diarrhoea treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Bausch Health Companies Inc., COSMO Pharmaceuticals, Immuron Ltd., and Sanofi SA, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global biosurgery market attained a value of more than USD 13.4 billion in 2021, driven by the prevalence of different biosurgeries. Aided by advancements in healthcare structure, the market is ex...
The global albumin market attained a value of USD 5.3 billion in 2021, driven by the rising benefits of HSA on commercial and therapeutic applications. Aided by advancements in nanotechnology for drug...
The global hydrophobic interaction chromatography market attained a value of over USD 320.3 million in 2021, driven by the increased demand for monoclonal antibodies. Aided by the rising investments i...
The global peptide therapeutics market attained a value of 31.4 billion in 2021, driven by the increasing prevalence of cancer. Aided by the increasing clinical trials and the growing FDA approval of ...
The global nicotine replacement therapy market attained a value of more than USD 44.7 billion in 2021, driven by the growing prevalence of health-related issues associated with cigarette smoking. Aide...
NEWSLETTER